Categories: aggregated

New THC-CBD Pill for MS and Huntington’s Disease May Be First to Benefit from Biden’s New Marijuana Research Bill

In related news, President Biden signed the Marijuana Research and Expansion Act into law. This will speed up researchers’ bids for DEA schedule 1 registration authorization to undertake these trials. After seven hard years of waiting, the MMJ group of firms can finish their mission of performing clinical studies on Huntington’s Disease and Multiple Sclerosis. MMJ has received FDA Orphan Designation for its Huntington’s disease clinical trials.

Jason

Share
Published by
Jason

Recent Posts

Can’t Visualize Something, Try Smoking Weed! – New Medical Study Shows Cannabis Works for Aphantasia Patients

However, a glimmer of hope has emerged from an unlikely source: cannabis. Some individuals with…

2 days ago

Life After AI – 10 Tips to Reinvent Yourself after AI Takes Your Job and Your Girlfriend

Nevertheless, this thought experiment raises a crucial issue that we, as a society, must grapple…

2 days ago

Leafly’s top 5 delta-9 THC gummies of 2024

Find the best delta-9 THC gummies of 2024. Leafly reviewed popular delta-9 THC gummies &…

3 days ago

The 10 Best Twitter (X) Cannabis Handles to Follow for Marijuana News and Updates

We shall look at the top 10 Twitter (X) handles that offer exclusive information to…

3 days ago

How Long Does Weed Stay in Your Saliva? – Mouth Swab Drug Test Guide

Understanding how long marijuana stays in saliva i s crucial for various reasons, including legal…

3 days ago

Science Discovers Cannabis Tolerance Levels – New Study Says Frequency of Marijuana Use Could Effect Cognitive and Motor Skills

Alright, let's dive into this groundbreaking study with all the seriousness it deserves - which…

3 days ago